Democrats on the Senate Finance Committee called on chairman Mike Crapo to launch a bipartisan probe into the Justice Department’s new weaponization fund.
Having secured deals with AstraZeneca and Novartis, Niowave is constructing a second facility to meet rising demand for actinium-225, which can be used to develop next-generation radiopharmaceuticals.
Eli Lilly, with a busier-than-ever business development team, has made a major vaccine play‚ months after hiring veteran vaccine regulator Peter Marks following his FDA departure.
Eli Lilly is the first pharma company to take first place in both categories in the eight years that intelligence firm IDEA Pharma has put out its analysis. Skyrocketing sales and multiple FDA approvals helped the company shoot to the top.
AI governance is waiting its Ferdinand Pecora, counsel to the Senate Banking Committee in the 1930s, who built the evidentiary foundation for every protector system that followed.
Plus, GASB looks for a new board member; CohnReznick launches a public finance and sustainability practice; Tommye Barie gets the AICPA Gold Medal Award of Distinction; and other firm and personnel news.